GlycoMimetics Inc [NASDAQ: GLYC] closed the trading session at $0.19.
The stocks have a year to date performance of -92.16 percent and weekly performance of 2.78 percent. The stock has been moved at -94.44 percent over the last six months. The stock has performed -42.88 percent around the most recent 30 days and changed -35.96 percent over the most recent 3-months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
If compared to the average trading volume of 3.77M shares, GLYC reached to a volume of 4020583 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about GlycoMimetics Inc [GLYC]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for GLYC shares is $0.75 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on GLYC stock is a recommendation set at 2.50. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
TD Cowen have made an estimate for GlycoMimetics Inc shares, keeping their opinion on the stock as Hold, with their previous recommendation back on July 26, 2024. While these analysts kept the previous recommendation, CapitalOne raised their target price to Overweight. The new note on the price target was released on December 22, 2023, representing the official price target for GlycoMimetics Inc stock. Previously, the target price had yet another raise from $3 to $4, while Jefferies kept a Buy rating on GLYC stock.
The Average True Range (ATR) for GlycoMimetics Inc is set at 0.02, with the Price to Sales ratio for GLYC stock in the period of the last 12 months amounting to 1192.88. The Price to Book ratio for the last quarter was 0.59, with the Price to Cash per share for the same quarter was set at 0.35.
GLYC stock trade performance evaluation
GlycoMimetics Inc [GLYC] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 2.78. With this latest performance, GLYC shares dropped by -42.88% in over the last four-week period, additionally sinking by -94.44% over the last 6 months – not to mention a drop of -88.22% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for GLYC stock in for the last two-week period is set at 37.75, with the RSI for the last a single of trading hit 41.59, and the three-weeks RSI is set at 35.27 for GlycoMimetics Inc [GLYC]. The present Moving Average for the last 50 days of trading for this stock 0.2497, while it was recorded at 0.1775 for the last single week of trading, and 1.6213 for the last 200 days.
GlycoMimetics Inc [GLYC]: An insightful look at the core fundamentals
GlycoMimetics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 5.48 and a Current Ratio set at 5.48.
GlycoMimetics Inc [GLYC]: Institutional Ownership
There are presently around $34.97%, or 38.37%% of GLYC stock, in the hands of institutional investors. The top three institutional holders of GLYC stocks are: BVF INC/IL with ownership of 9.54 million shares, which is approximately 14.8217%. ARTAL GROUP S.A., holding 8.59 million shares of the stock with an approximate value of $$25.77 million in GLYC stocks shares; and ARTAL GROUP S.A., currently with $$11.51 million in GLYC stock with ownership which is approximately 5.9556%.
